← Back to Search

Analgesic Properties of Oral Sucrose During Immunizations

N/A
Waitlist Available
Led By Linda A Hatfield, PhD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine

Summary

The purpose of this study is to examine the analgesic properties of oral sucrose during routine immunizations. Hypothesis: Oral sucrose solution and maternal contact will significantly decrease the objective measures of acute pain during routine immunizations.

Eligible Conditions
  • Procedural Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Behavioral pain response

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SucroseExperimental Treatment1 Intervention
Participants received oral sucrose (0.6mL/Kg) 2 minutes prior to the combind DTaP, IPV, and Hep B (Hib and PCV7) vaccine.
Group II: PlaceboPlacebo Group1 Intervention
Participants received Placebo (sterile water, 0.6mL/Kg) 2 minutes prior to the combind DTaP, IPV, and Hep B (Hib and PCV7) vaccine.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
511 Previous Clinical Trials
2,870,762 Total Patients Enrolled
1 Trials studying Procedural Pain
140 Patients Enrolled for Procedural Pain
Linda A Hatfield, PhDPrincipal InvestigatorThe Penn State University
~5 spots leftby Jan 2026